“Cost-Effectiveness Profile, Organizational Implications and Patient Preferences on the Use of Exogenous TSH Therapy (Thyrogen®) Vs. THW in Thyroid Residue Ablation in Italy”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (3). https://doi.org/10.7175/fe.v17i3.1264.